1. Home
  2. ATOS vs DLTH Comparison

ATOS vs DLTH Comparison

Compare ATOS & DLTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATOS
  • DLTH
  • Stock Information
  • Founded
  • ATOS 2009
  • DLTH 1989
  • Country
  • ATOS United States
  • DLTH United States
  • Employees
  • ATOS N/A
  • DLTH N/A
  • Industry
  • ATOS Biotechnology: Pharmaceutical Preparations
  • DLTH Clothing/Shoe/Accessory Stores
  • Sector
  • ATOS Health Care
  • DLTH Consumer Discretionary
  • Exchange
  • ATOS Nasdaq
  • DLTH Nasdaq
  • Market Cap
  • ATOS 112.7M
  • DLTH 131.7M
  • IPO Year
  • ATOS 2012
  • DLTH 2015
  • Fundamental
  • Price
  • ATOS $1.01
  • DLTH $4.02
  • Analyst Decision
  • ATOS Strong Buy
  • DLTH Buy
  • Analyst Count
  • ATOS 3
  • DLTH 1
  • Target Price
  • ATOS $6.25
  • DLTH $7.00
  • AVG Volume (30 Days)
  • ATOS 762.2K
  • DLTH 216.4K
  • Earning Date
  • ATOS 11-11-2025
  • DLTH 09-04-2025
  • Dividend Yield
  • ATOS N/A
  • DLTH N/A
  • EPS Growth
  • ATOS N/A
  • DLTH N/A
  • EPS
  • ATOS N/A
  • DLTH N/A
  • Revenue
  • ATOS N/A
  • DLTH $602,746,000.00
  • Revenue This Year
  • ATOS N/A
  • DLTH N/A
  • Revenue Next Year
  • ATOS N/A
  • DLTH $0.24
  • P/E Ratio
  • ATOS N/A
  • DLTH N/A
  • Revenue Growth
  • ATOS N/A
  • DLTH N/A
  • 52 Week Low
  • ATOS $0.55
  • DLTH $1.58
  • 52 Week High
  • ATOS $1.66
  • DLTH $4.66
  • Technical
  • Relative Strength Index (RSI)
  • ATOS 77.26
  • DLTH 64.42
  • Support Level
  • ATOS $0.81
  • DLTH $3.39
  • Resistance Level
  • ATOS $0.90
  • DLTH $3.94
  • Average True Range (ATR)
  • ATOS 0.04
  • DLTH 0.31
  • MACD
  • ATOS 0.02
  • DLTH -0.04
  • Stochastic Oscillator
  • ATOS 83.33
  • DLTH 62.38

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

About DLTH Duluth Holdings Inc. Class B

Duluth Holdings Inc is an apparel brand in the United States. The company offers shirts, pants, and casual wear for men and women under brands like Alaskan Hardgear, Armachillo, Ballroom, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No Polo Shirt, No Yank, Wild Boar, and others. The Company's revenue consists of the sale of apparel, footwear, and hard goods. The company operates in a single operating segment.

Share on Social Networks: